Overall, the number of patients discharged from hospitals with an ulcerative colitis diagnosis increased between 2009 and 2018, but the number of patients opting for ileal pouch–anal anastomosis (IPAA ...

"The early identification of patients at risk for the development of pouchitis remains an unmet need given that patients developing pouchitis in the first year after IPAA have demonstrated an ...

Vedolizumab appears to be effective at reducing intestinal inflammation and inducing remission in patients who developed chronic pouchitis after undergoing ileal pouch-anal anastomosis (IPAA) for ...

Pouchitis is the most common condition that develops following ileal pouch-anal anastomosis. More than one-half of patients with ulcerative colitis (UC) develop intermittent pouchitis within 1 year ...

Can Surgery Cure Ulcerative Colitis? Alan Moss, MD, chief scientific officer of the Crohns & Colitis Foundation, clearly explains the surgeries available to people with ulcerative colitis, and their ...

"These findings are significant, as individuals with delayed closure for nonmedical reasons or pouch complications do not have heightened risk of developing endoscopic pouch inflammation, and, ...

An eight-strain probiotic has been shown to reduce the risk for pouchitis in patients with ulcerative colitis who undergo ileal pouch anal anastomosis (IPAA), but its cost-effectiveness depends on ...

Mark Gurarie is a writer covering health topics, technology, music, books, and culture. He also teaches health science and research writing at George Washington University's School of Medical and ...